Ligand validation:8IRI

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRI_SQD_a_411	75%	32%	0.126	0.959	0.96	1.83	3	13	0	0	100%	0.49
8IRI_SQD_A_410	68%	32%	0.133	0.945	0.93	1.88	3	10	0	0	100%	0.49
8IRI_SQD_X_101	42%	22%	0.169	0.924	1.2	2.16	4	13	0	0	80%	0.7963
8IRI_SQD_B_620	30%	30%	0.158	0.82	1.07	1.83	3	13	0	0	100%	1
8IRI_SQD_A_412	30%	41%	0.177	0.838	1.05	1.28	3	6	0	0	100%	1
8IRI_SQD_a_412	26%	43%	0.198	0.836	1.08	1.19	4	9	0	0	100%	1
8IRI_SQD_b_620	24%	33%	0.181	0.808	1.04	1.72	3	13	0	0	100%	1
8IRI_SQD_f_102	5%	34%	0.328	0.778	1.23	1.48	3	10	0	0	80%	0.7963
5V2C_SQD_a_413	94%	24%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	77%	23%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	32%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	75%	33%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	75%	32%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	33%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.